Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
about
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryCurcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-SynucleinSynthesis, characterization and fluorescent properties of water-soluble glycopolymer bearing curcumin pendant residues.Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - A review.Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy.Computational analyses of curcuminoid analogs against kinase domain of HER2(Z)-4-Benzyl-idene-3-methyl-isoxazol-5(4H)-one3-(4-Meth-oxy-phen-yl)-5-methylisoxazole-4-carb-oxy-lic acidMonocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.Multifaceted roles of curcumin: two sides of a coin!Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met.Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA).New structural classes of antituberculosis agents.Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection.Ethyl 5-(4-amino-phen-yl)isoxazole-3-carboxyl-ate.Synthesis and biological evaluation of some novel urea and thiourea derivatives of isoxazolo[4,5-d]pyridazine and structurally related thiazolo[4,5-d]pyridazine as antimicrobial agents.A reduced curcuminoid analog as a novel inducer of fetal hemoglobin.Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis.A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting new Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 β (GSK-3β).Crystal structure and Hirshfeld surface analysis of (Z)-4-(4-hy-droxy-benzyl-idene)-3-methyl-isoxazol-5(4H)-one.
P2860
Q24630927-D8B1724C-A0F9-4617-8780-F4C45A1E0251Q30410869-9B6E3E12-9E38-4766-B8F3-B7EB1E58D8CFQ31081880-8D5C445D-8939-4D81-BF26-E2695A74325FQ33553083-2C4D9C44-BDC2-4FFC-83CC-8BC1564E2644Q33854476-BEBC9E2F-F99A-4A2A-A523-DEDA78675F78Q34084939-DFCBC800-F6F0-49C5-B66E-20B2D6B79983Q36447794-BE15A9AD-EB35-44EE-8C2A-5038626EDD44Q36657153-F1DA9F50-3DC5-45F1-A947-ED0188346166Q36694988-761041B1-1373-4C3B-9F43-9210CE737413Q37937617-29133FE5-7C92-4DDC-8FC1-B56DFC4C521CQ38733962-BA5350BB-1066-4DDF-B2B6-CBB3E25F378DQ39023369-4A8E9782-A0DA-49A5-9307-FACBB32C112BQ39362128-2DBB7C38-D139-4B84-8D96-CB980F8D277DQ40741808-65878228-94FE-48F6-9327-9D6B2976B1A4Q42069382-A6263198-4EC1-4108-A4B2-B8264B522C6AQ42711440-9FC6A0D4-3DDF-4B78-9409-55A3448E27BCQ44238537-B9D16A9D-0150-466A-88F1-F4D8E875600BQ47895693-65FD4EB5-F75E-419C-8DA0-97871A04C19EQ54263064-6DCE33E7-D8D2-4F88-91DE-FFE77CADA964Q55690335-EC542335-4D49-467D-8AA9-3A13F338D1E9
P2860
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@en
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@nl
type
label
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@en
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@nl
prefLabel
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@en
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@nl
P2093
P1476
Isoxazole analogs of curcumino ...... nt antimycobacterial activity.
@en
P2093
Apichart Suksamrarn
Chatchawan Changtam
Poonpilas Hongmanee
P304
P356
10.1016/J.EJMECH.2010.07.003
P577
2010-08-05T00:00:00Z